$75.88
+4.84%Oct 20, 2026, 20:35 UTC
ALCON INC acquired Neurotech and its ENCELTO treatment for MacTel Type 2.
Oct 2, 2026, 22:00 UTC
McKinney Health debuted its Living Experience Ambassador Programs (L.E.A.P.) patient advocacy offering on Monday.
Source:Sep 3, 2026, 13:00 UTC
Alcon launched UNITY M, a premium ophthalmic microscope, in Geneva.
Source:Aug 31, 2026, 19:14 UTC
President Donald J. Trump announced agreements with nine additional pharmaceutical manufacturers to lower drug prices for Americans in line with most-favored-nation pricing.
Aug 26, 2026, 21:00 UTC
Alcon priced a EUR 500 million senior notes offering.
Source:Aug 13, 2026, 16:00 UTC
Pershing Square, led by Bill Ackman, disclosed in a shareholder letter that it has made new investments in six stocks since its IPO, including Visa, Mastercard, Netflix, S&P Global, ICE, and Alcon.
Aug 12, 2026, 21:33 UTC
Pershing Square Holdings announced in a shareholder letter that it has made six new investments since its IPO, including Visa, Mastercard, Netflix, S&P Global, Intercontinental Exchange, and Alcon.
Aug 11, 2026, 14:43 UTC
Alcon's shares jumped roughly 4% on Tuesday after the company raised its 2026 profitability outlook.
Source:Aug 10, 2026, 23:01 UTC
Alcon reported its Q2 2026 earnings, with revenue and EPS compared to Wall Street estimates and year-ago figures.
Aug 10, 2026, 20:30 UTC
Alcon launched new products in the second quarter of 2026, contributing to its growth.
Aug 3, 2026, 17:46 UTC
The Swiss Market Index (SMI) closed marginally up on Monday, with Logitech International and Sonova leading gains, while Sandoz Group and Holcim declined.
Source:Jul 11, 2026, 02:02 UTC
RxSight announced a strategic collaboration agreement with Alcon.
Source:Jul 6, 2026, 20:15 UTC
Alcon and RxSight announced a non-exclusive license agreement to collaborate on the development and commercialization of novel post-operative light adjustable PCIOL technologies.
Source:Jun 30, 2026, 11:55 UTC
The Delaware Court of Chancery dismissed a shareholder derivative suit against Alcon Research, Deerfield, Petrichor, and Aurion Biotech directors, brought by former co-founder David Rostov, over alleged governance changes that frustrated Aurion Biotech's planned IPO.
Source:Jun 15, 2026, 13:43 UTC
Alcon launched the UNITY® Cataract System (CS) in Canada at COS 2026.
Source: